We are live on ! Find out more
VFA

Values First Advisors Portfolio holdings

AUM $192M
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
AUM
$167M
AUM Growth
-$3.71M
Cap. Flow
-$3.88M
Cap. Flow %
-2.32%
Top 10 Hldgs %
28.47%
Holding
184
New
17
Increased
71
Reduced
77
Closed
15

Top Buys

Rank Stock Value
1
LOPE icon
Grand Canyon Education
LOPE
+$1.93M
2
HCKT icon
Hackett Group
HCKT
+$1.84M
3
BMI icon
Badger Meter
BMI
+$1.67M
4
MED icon
Medifast
MED
+$1.16M
5
TECH icon
Bio-Techne
TECH
+$499K

Sector Composition

Rank Sector Weight
1 Healthcare 16.7%
2 Technology 16.01%
3 Industrials 10.93%
4 Real Estate 6.56%
5 Consumer Discretionary 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AURA icon
151
Aura Biosciences
AURA
$729M
$137K 0.08%
18,124
-9,167
-34% -$67.1K
BLRX
152
BioLineRX
BLRX
$12.3M
$116K 0.07%
5,094
+3
+0.1% +$81
GERN icon
153
Geron
GERN
$911M
$115K 0.07%
+27,006
New +$105K
GIFI
154
DELISTED
Gulf Island Fabrication
GIFI
$111K 0.07%
18,328
-5,345
-23% -$35.9K
TLPH icon
155
Talphera
TLPH
$70.1M
$101K 0.06%
113,175
-240
-0.2% -$245
CENTA icon
156
Central Garden & Pet Co Class A
CENTA
$2.41B
$84.3K 0.05%
2,553
-6
-0.2% -$216
PLUR icon
157
Pluri
PLUR
$19.2M
$82.6K 0.05%
14,285
+430
+3% +$2.43K
INZY
158
DELISTED
Inozyme Pharma
INZY
$76.1K 0.05%
+17,067
New +$82.8K
MRNS
159
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$73.3K 0.04%
62,671
+52,257
+502% +$131K
NKTR icon
160
Nektar Therapeutics
NKTR
$2.39B
$56K 0.03%
+3,013
New +$63.5K
ISMD icon
161
Inspire Small/Mid Cap Impact ETF
ISMD
$335M
$31.3K 0.02%
903
+204
+29% +$7.08K
JBIO
162
Jade Biosciences
JBIO
$1.22B
$25.5K 0.02%
+439
New +$291K
IBD icon
163
Inspire Corporate Bond ETF
IBD
$481M
$16.6K 0.01%
710
+117
+20% +$2.73K
CWB icon
164
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$9.42K 0.01%
131
+115
+719% +$8.23K
VMBS icon
165
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$3.18K ﹤0.01%
70
PFF icon
166
iShares Preferred and Income Securities ETF
PFF
$13.2B
$1.58K ﹤0.01%
+50
New +$1.57K
SPMB icon
167
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.96B
$280 ﹤0.01%
13
FLRN icon
168
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$171 ﹤0.01%
6
VCSH icon
169
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$162 ﹤0.01%
2
AMZN icon
170
Amazon
AMZN
$2.5T
-1,300
Closed -$234K
APTV icon
171
Aptiv
APTV
$12B
-5,806
Closed -$462K
COUR icon
172
Coursera
COUR
$1.54B
-41,669
Closed -$584K
DGII icon
173
Digi International
DGII
$2.52B
-7,163
Closed -$229K
DLO icon
174
dLocal
DLO
$4.26B
-32,477
Closed -$477K
FTNT icon
175
Fortinet
FTNT
$112B
-27,735
Closed -$1.89M

Similar funds

Values First Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Values First Advisors held 184 positions worth $167M, down 2.2% from $171M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Values First Advisors's Q2 2024 filing shows 17 new, 71 increased, 77 reduced and 15 closed positions. Its largest new stake was Grand Canyon Education: 14,018 shares worth $1.96M. The largest sale was SS&C Technologies, an estimated $2.07M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Values First Advisors's largest Q2 2024 buy was Grand Canyon Education: 14,018 shares worth $1.96M.
  • Values First Advisors added most to Medifast in Q2 2024, an estimated $1.16M increase.
  • Values First Advisors's biggest Q2 2024 reduction was Amphenol, cutting an estimated $1.06M.
  • Values First Advisors fully exited SS&C Technologies in Q2 2024, selling an estimated $2.07M.
  • Values First Advisors's ten largest holdings make up 28% of its $167M portfolio in Q2 2024.
  • Values First Advisors opened 17 new positions and closed 15 in Q2 2024.
  • Values First Advisors's portfolio value fell 2.2% quarter-over-quarter to $167M.

Based on Values First Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.